Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Idoven’s Willem™ AI platform enables rapid and accurate ECG interpretation at scale. It detects over 86 types of electrical heart disturbances—covering about 90% of common cardiac problems—and can analyze up to fifty thousand heartbeats in under a minute. The system has been validated on data from more than forty-nine thousand patients and supports remote monitoring globally. Clinical results include improved speed and accuracy of diagnosis compared to traditional manual review by cardiologists. The company collaborates with leading research centers and industry partners on projects such as MAESTRIA H2020 for stroke and atrial fibrillation research. No drug or therapeutic clinical trial results are reported; the focus is on diagnostic/monitoring technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Idoven.